IGM Biosciences, Inc.
IGMSDelisted Aug 14, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496323
IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding IGM Biosciences, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 85 | 1 | 79 | −5 |
| Shares | 21.7M | 45.0K | 17.8M | −3.87M (−17.9%) |
| Value | $132.8M | $275.0K | $20.5M | −$112.1M (−84.6%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held IGM Biosciences, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AQR Capital Management LLC | 238,871 | $274.7K | 0.00% |
| Verition Fund Management LLC | 119,068 | $136.9K | 0.00% |
| Two Sigma Advisers, LP | 90,500 | $104.1K | 0.00% |
| Acadian Asset Management LLC | 85,807 | $97.0K | 0.00% |
| Nuveen, LLC | 45,015 | $51.8K | 0.00% |
| Ieq Capital, LLC | 37,422 | $43.0K | 0.00% |
| Invesco Ltd. | 36,127 | $41.5K | 0.00% |
| Qube Research & Technologies Ltd | 32,821 | $37.7K | 0.00% |
| Virtus Investment Advisers, Inc. | 19,974 | $23.0K | 0.01% |
| JustInvest LLC | 13,841 | $15.9K | 0.00% |
| Two Sigma Securities, LLC | 13,486 | $15.5K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 11,584 | $13.3K | 0.00% |
| Intech Investment Management LLC | 11,069 | $12.7K | 0.00% |
| Federated Hermes, Inc. | 6,022 | $6.92K | 0.00% |
| Coldstream Capital Management Inc | 2,626 | $3.02K | 0.00% |
| CoreCap Advisors, LLC | 2,234 | $2.57K | 0.00% |
| UBS Asset Management Americas Inc | 1,164 | $1.34K | 0.00% |
| EverSource Wealth Advisors, LLC | 337 | $387 | 0.00% |
| True Wealth Design, LLC | 271 | $312 | 0.00% |
| Capital Advisors, Ltd. LLC | 258 | $0 | 0.00% |
Sold out (25)
Institutions that held IGM Biosciences, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
Not filed for Q1 2025 yet (1)
Institutions that held IGM Biosciences, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 45,015 | $275.0K |